Biotech Values

[biopharm]

What, pray tell, would that answer be?

With all due respect DD, I believe its rather predictable for some to stake claim and call a small biotech stock a "scam" because 80% of them never make it. Now for all these "scam" type stocks to fall... there are many times never charges or investigations into the depth of how the stock actually became a "scam".

On the flip side, there are many fines to many Big Pharma for paying off doctors, analysts, travel agencies, CRO's inside and outside the US...etc..etc..etc, but I guess one can also claim that a fine represents a "scam" upon any particular Big Pharma.

The most difficult prediction ever to make.... would select not the 4 out of 5 small biotechs that will never make it and call some of them "scams" --- but to investigate, research and perform due diligence like not many do and don't trust anything but the research that says a small biotech will truly not only be one of those 5 small biotechs that make it.... but rather one of the very few that present a "biotech value" unlike all others.

I say that "biotech value" is Peregrine Pharmaceuticals.

Some say its a scam, placebo, drug doesn't work, management faulty... whatever it may be.

I say the majority of quality CEO's within the small biotech arena fail to rise to the top because they are only as good as their lead drug candidate....and even then, those CEO's don't truly know at the early stages how valuable their pipeline actually may be.

CEO Steve King looks to be that CEO that didn't sell out early and resisted mainstream thinking, as many would partner early on and take some early profits and give future success to Big Pharma. CEO Steve King may have taken that road less traveled, but Big Pharma surely was keeping a close Fargo eye on that road traveled.

Now, we have to ask ourselves why would someone take this road less traveled? I say it all goes back to you can only be as successful as your lead drug candidate and Bavituximab is much more than a drug for one indication.

Combination trials speak for themselves.... if they result in seeing "overall responses" of 200-300% than any of those drugs can achieve by themselves... then its Bavituximab that everyone will be after.

A scam? .... or a "biotech value" ? .....Everyone knows what path I have chosen.